The President of the United States of America has spent the past few weeks touting a dangerous drug called hydroxychloroquine as a prophylactic treatment for COVID-19. Unfortunately, the president's expertise is in reality TV, not medicine. Several studies have shown that hydroxychloroquine, a drug designed to treat malaria, has dangerous side-effects when used to treat coronavirus, including death.The quest for a COVID-19 drug that will both make Donald Trump and his friends in the pharmaceutical industry rich and not kill the people who take it has, so far, netted no results. But exciting government-sponsored research out of Canada seems to indicate a different approach is in order.
Per the team's research paper:
We have developed over 800 new Cannabis sativa lines and extracts and hypothesized that high-CBD C. sativa extracts may be used to modulate ACE2 expression in COVID-19 target tissues. Screening C. sativa extracts using artificial human 3D models of oral, airway, and intestinal tissues, we identified 13 high CBD C. sativa extracts that modulate ACE2 gene expression and ACE2 protein levels.